Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 9/2020

01-09-2020 | Ebola Virus | Viewpoint

COVID-19: Why Declining Biodiversity Puts Us at Greater Risk for Emerging Infectious Diseases, and What We Can Do

Author: Aditya K. Khetan, MD

Published in: Journal of General Internal Medicine | Issue 9/2020

Login to get access

Excerpt

Emerging infectious diseases (EID), which include zoonotic diseases, drug-resistant pathogens, and vector-borne pathogens, have been increasing steadily since 1940.1 Most of this increase has been due to zoonotic pathogens from wildlife; common examples of which are HIV, Ebola, SARS, MERS, and, now, COVID-19. For every decade since 1940, there has been a consistent increase in the number of EID events from wildlife-related zoonosis. Human activity is the primary driver of this increase, with loss of biodiversity a leading mechanism.2 …
Literature
1.
Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, et al. Global trends in emerging infectious diseases. Nature. 2008;451(7181):990–993.CrossRef
2.
Keesing F, Belden LK, Daszak P, Dobson A, Harvell CD, Holt RD, et al. Impacts of biodiversity on the emergence and transmission of infectious diseases. Nature. 2010;468(7324):647–652.CrossRef
3.
Redford K. Human influences on biodiversity. Glob Biodivers Assess Eds VH Heywood RT Watson. 1995;711–822.
4.
Hoberg EP, Brooks DR. Evolution in action: climate change, biodiversity dynamics and emerging infectious disease. Philos Trans R Soc B Biol Sci. 2015;370(1665):20130553.CrossRef
5.
Whitmee S, Haines A, Beyrer C, Boltz F, Capon AG, de Souza Dias BF, et al. Safeguarding human health in the Anthropocene epoch: report of The Rockefeller Foundation–Lancet Commission on planetary health. Lancet. 2015;386(10007):1973–2028.CrossRef
6.
Gibbs HK, Ruesch AS, Achard F, Clayton MK, Holmgren P, Ramankutty N, et al. Tropical forests were the primary sources of new agricultural land in the 1980s and 1990s. Proc Natl Acad Sci. 2010;107(38):16732–16737.CrossRef
7.
Kim BF, Santo RE, Scatterday AP, Fry JP, Synk CM, Cebron SR, et al. Country-specific dietary shifts to mitigate climate and water crises. Glob Environ Chang. 2019;101926.
Metadata
Title
COVID-19: Why Declining Biodiversity Puts Us at Greater Risk for Emerging Infectious Diseases, and What We Can Do
Author
Aditya K. Khetan, MD
Publication date
01-09-2020
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 9/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-020-05977-x

Other articles of this Issue 9/2020

Journal of General Internal Medicine 9/2020 Go to the issue

Concise Research Report

Risk for Severe COVID-19 Illness Among Health Care Workers Who Work Directly with Patients

Concise Research Report

Association Between State-Level Income Inequality and COVID-19 Cases and Mortality in the USA

Concise Research Report

State Voting Patterns in the 2016 Presidential Election and Uninsured Rates in Non-elderly Adults

Original Research

Identifying Performance Outliers for Stroke Care Based on Composite Score of Process Indicators: an Observational Study in China

Clinical Vignette

A Case of E-cigarette, or Vaping, Product Use–Associated Lung Injury (EVALI) in a Previously Healthy Patient: Case Report and Literature Review

Letter to the Editor

Letter to the Editor in Response to: COVID-19: Magnifying the Effect of Health Disparities

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits